Viyash Scientific Overview
- Year Founded
-
1985
- Status
-
Public
- Employees
-
4,131
- Stock Symbol
-
512529
- Investments
-
8
- Share Price
-
$2.50
- (As of Friday Closing)
Viyash Scientific General Information
Description
Viyash Scientific Ltd is engaged in the business of pharmaceuticals. The Company manufactures Active Pharmaceutical Ingredients (APIs), intermediates, finished formulations, and provides research and testing activities. It offers a comprehensive portfolio of APIs, intermediates, and formulations for human and animal health to serve diverse therapeutic needs. Its human API portfolio focuses on complex and niche molecules across key therapeutic areas, including potent segments such as oncology and immunology. The Company operates in the pharmaceuticals business and serves India, the USA, Spain and the Rest of the World, with maximum revenue generated from India.
Contact Information
Website
www.viyash.comCorporate Office
- Plot Number 290, Srivaili's Corporate
- Road Number 6, Madhapur
- Hyderabad, Telangana 500033
- India
Corporate Office
- Plot Number 290, Srivaili's Corporate
- Road Number 6, Madhapur
- Hyderabad, Telangana 500033
- India
Viyash Scientific Stock Performance
As of 20-Nov-2026, Viyash Scientific’s stock price is $2.50. Its current market cap is $1.1B with 442M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.50 | $2.52 | $1.90 - $3.13 | $1.1B | 442M | 355K | $0.06 |
Viyash Scientific Financials Summary
As of 30-Sep-2026, Viyash Scientific has a trailing 12-month revenue of $400M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 1,127,499 | 895,853 | 436,968 | 398,992 |
| Revenue | 400,422 | 379,903 | 350,461 | 165,040 |
| EBITDA | 76,784 | 72,109 | 38,363 | 6,359 |
| Net Income | 25,085 | 20,063 | 2,746 | (4,333) |
| Total Assets | 534,201 | 490,542 | 483,084 | 184,713 |
| Total Debt | 60,821 | 51,907 | 76,491 | 58,481 |
Viyash Scientific Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Viyash Scientific Comparisons
Industry
Financing
Details
Viyash Scientific Competitors (5)
One of Viyash Scientific’s 5 competitors is Phibro Animal Health, a Formerly PE-Backed company based in Teaneck, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Phibro Animal Health | Formerly PE-Backed | Teaneck, NJ | ||||
| Ashish Life Science | Venture Capital-Backed | Mumbai, India | ||||
| Mallinckrodt Pharmaceuticals | Formerly PE-Backed | Dublin, Ireland | ||||
| Pil-psychotropics India | Corporation | Faridabad, India | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India |
Viyash Scientific Patents
Viyash Scientific Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018109781-A1 | A process for the preparation of firocoxib | Inactive | 13-Dec-2016 | ||
| US-20140100385-A1 | Process for preparation of succinylcholine chloride | Inactive | 08-Oct-2012 | ||
| WO-2013065064-A1 | A process for preparation of l-(6-methylpyridin-3-yl)-2-[4-(meth.ylsulfonyi)phenyl]ethanone field of invention | Inactive | 31-Oct-2011 | ||
| WO-2013021398-A2 | A process for preparation of mivacurium chloride | Inactive | 05-Aug-2011 | ||
| WO-2013021398-A3 | A process for preparation of mivacurium chloride | Inactive | 05-Aug-2011 | C07D217/20 |
Viyash Scientific Signals
Viyash Scientific Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Viyash Scientific Investments & Acquisitions (8)
Viyash Scientific’s most recent deal was a Merger/Acquisition with Viyash Life Sciences. The deal was made on 21-Jan-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Viyash Life Sciences | 21-Jan-2025 | Merger/Acquisition | Pharmaceuticals | ||
| Vindhya Pharma | 01-Sep-2019 | Merger/Acquisition | Distributors/Wholesale | ||
| Solara Active Pharma Sciences (EU-GMP API facility located at Mahad, Maharashtra) | 01-Aug-2018 | Corporate Asset Purchase | Buildings and Property | ||
| Naari Pharma India | 01-Jan-2016 | Merger/Acquisition | Pharmaceuticals | ||
| Alivira Animal Health | 31-Mar-2015 | Secondary Transaction - Private | Other Pharmaceuticals and Biotechnology |
Viyash Scientific ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Viyash Scientific Exits (1)
Viyash Scientific’s most recent exit was on 01-Jan-2016 from Naari Pharma India. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Naari Pharma India | 01-Jan-2016 | Completed |
|
Viyash Scientific Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Viyash Life Sciences | Hyderabad, India | 2019 | |
| Alivira Animal Health | Mumbai, India | 2013 | |
| SeQuent Scientific (Pharmaceutical Ingredient Unit in Thane) | Thane, India |
Viyash Scientific FAQs
-
When was Viyash Scientific founded?
Viyash Scientific was founded in 1985.
-
Where is Viyash Scientific headquartered?
Viyash Scientific is headquartered in Hyderabad, India.
-
What is the size of Viyash Scientific?
Viyash Scientific has 4,131 total employees.
-
What industry is Viyash Scientific in?
Viyash Scientific’s primary industry is Other Commercial Products.
-
Is Viyash Scientific a private or public company?
Viyash Scientific is a Public company.
-
What is Viyash Scientific’s stock symbol?
The ticker symbol for Viyash Scientific is 512529.
-
What is the current stock price of Viyash Scientific?
As of 20-Nov-2026 the stock price of Viyash Scientific is $2.50.
-
What is the current market cap of Viyash Scientific?
The current market capitalization of Viyash Scientific is $1.1B.
-
What is Viyash Scientific’s current revenue?
The trailing twelve month revenue for Viyash Scientific is $400M.
-
Who are Viyash Scientific’s competitors?
Phibro Animal Health, Ashish Life Science, Mallinckrodt Pharmaceuticals, Pil-psychotropics India, and Glenmark Pharmaceuticals are competitors of Viyash Scientific.
-
What is Viyash Scientific’s annual earnings per share (EPS)?
Viyash Scientific’s EPS for 12 months was $0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process